PubRank
Search
About
Zachary D Goodman
Author PubWeight™ 87.20
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Boceprevir for untreated chronic HCV genotype 1 infection.
N Engl J Med
2011
19.01
2
Boceprevir for previously treated chronic HCV genotype 1 infection.
N Engl J Med
2011
12.09
3
Liver biopsy.
Hepatology
2009
7.61
4
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
Gastroenterology
2008
6.15
5
Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment.
Gastroenterology
2004
4.27
6
Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
Hepatology
2008
2.02
7
Predicting cirrhosis in patients with hepatitis C based on standard laboratory tests: results of the HALT-C cohort.
Hepatology
2005
1.93
8
Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C.
Gut
2010
1.78
9
Giant cell tumor of the extrahepatic biliary tree: a clinicopathologic study of 4 cases and comparison with anaplastic spindle and giant cell carcinoma with osteoclast-like giant cells.
Am J Surg Pathol
2006
1.58
10
Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients.
Hepatology
2010
1.55
11
Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin.
Hepatology
2002
1.40
12
Final results of a double-blind, placebo-controlled trial of the antifibrotic efficacy of interferon-gamma1b in chronic hepatitis C patients with advanced fibrosis or cirrhosis.
Hepatology
2007
1.27
13
Best practices in diagnostic immunohistochemistry: hepatocellular carcinoma versus metastatic neoplasms.
Arch Pathol Lab Med
2007
1.19
14
Prognostic value of Ishak fibrosis stage: findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
Hepatology
2010
1.12
15
Liver biopsy in cirrhotic patients.
Am J Gastroenterol
2007
1.10
16
Rate of progression of hepatic fibrosis in patients with chronic hepatitis C: results from the HALT-C Trial.
Gastroenterology
2011
1.07
17
Diabetic hepatosclerosis: diabetic microangiopathy of the liver.
Arch Pathol Lab Med
2006
1.02
18
Calcifying nested stromal-epithelial tumors of the liver: a clinicopathologic, immunohistochemical, and molecular genetic study of 9 cases with a long-term follow-up.
Am J Surg Pathol
2009
1.01
19
Pathologic assessment of non-alcoholic fatty liver disease.
Clin Liver Dis
2007
1.01
20
Glypican-3 expression in benign liver tissue with active hepatitis C: implications for the diagnosis of hepatocellular carcinoma.
Hum Pathol
2007
0.99
21
Primary gallbladder sarcoma: a clinicopathologic study of 15 cases, heterogeneous sarcomas with poor outcome, except pediatric botryoid rhabdomyosarcoma.
Am J Surg Pathol
2009
0.97
22
Sustained long-term antiviral maintenance therapy in HCV/HIV-coinfected patients (SLAM-C).
J Acquir Immune Defic Syndr
2010
0.97
23
Histopathological changes after microwave coagulation therapy for patients with hepatocellular carcinoma: review of 15 explanted livers.
Am J Gastroenterol
2003
0.91
24
Segmental atrophy of the liver: a distinctive pseudotumor of the liver with variable histologic appearances.
Am J Surg Pathol
2011
0.91
25
Mallory-Denk bodies are associated with outcomes and histologic features in patients with chronic hepatitis C.
Clin Gastroenterol Hepatol
2011
0.90
26
Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease.
Obes Surg
2010
0.90
27
Fibrolamellar hepatocellular carcinoma: an immunohistochemical comparison with conventional hepatocellular carcinoma.
Int J Surg Pathol
2010
0.89
28
Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: a retrospective study.
Hepatology
2013
0.88
29
Idiopathic adulthood ductopenia associated with hepatitis C virus.
Dig Dis Sci
2002
0.85
30
Hepatic iron concentration does not influence response to therapy with interferon plus ribavirin in chronic HCV infection.
J Interferon Cytokine Res
2002
0.85
31
An immunohistochemical profile of the so-called bile duct adenoma: clues to pathogenesis.
Am J Surg Pathol
2010
0.84
32
Pathology of the liver sinusoids.
Histopathology
2014
0.83
33
Histologic evidence of active liver injury in chronic hepatitis B patients with normal range or minimally elevated alanine aminotransferase levels.
J Clin Gastroenterol
2010
0.83
34
Globular hepatic amyloid: an early stage in the pathway of amyloid formation: a study of 20 new cases.
Am J Surg Pathol
2007
0.81
35
Diagnosis of focal nodular hyperplasia of the liver by needle biopsy.
Hum Pathol
2005
0.80
36
Improvement in liver histology among Asian patients with chronic hepatitis B after long-term treatment with entecavir.
Liver Int
2013
0.79
37
Expression of estrogen and progesterone receptors and inhibin-alpha in hepatobiliary cystadenoma: an immunohistochemical study.
Virchows Arch
2007
0.78
38
Plasma Pro-C3 (N-terminal type III collagen propeptide) predicts fibrosis progression in patients with chronic hepatitis C.
Liver Int
2014
0.78
39
Hepatic adenocarcinoma expressing inhibin in a young patient on oral contraceptives.
Virchows Arch
2005
0.76
40
Elastography Assessment of Liver Fibrosis: Society of Radiologists in Ultrasound Consensus Conference Statement.
Ultrasound Q
2016
0.76
41
Inflammatory pseudotumor of the liver: a rare but distinct tumor-like lesion.
Gastroenterol Hepatol (N Y)
2012
0.76
42
More severe parenchymal injury in chronic hepatitis C acquired by recent injection drug use.
J Clin Gastroenterol
2005
0.76
43
Characterization of HCV NS3 Protease Variants in HCV/HIV Coinfected Patients by Ultra-deep Sequence Analysis: Relationship to Hepatic Fibrosis.
J Acquir Immune Defic Syndr
2016
0.75
44
Genetics and imaging of hepatocellular adenomas: 2011 update. Invited commentary.
Radiographics
2011
0.75
45
Correlates of adiponectin in hepatitis C-infected children: the importance of body mass index.
J Pediatr Gastroenterol Nutr
2015
0.75